- Home
- MTEX vs AKTX Comparison
MTEX vs AKTX Comparison
Compare MTEX & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- AKTX
- Stock Information
- Founded
- MTEX 1993
- AKTX N/A
- Country
- MTEX United States
- AKTX United States
- Employees
- MTEX N/A
- AKTX N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- MTEX Health Care
- AKTX Health Care
- Exchange
- MTEX Nasdaq
- AKTX Nasdaq
- Market Cap
- MTEX 19.9M
- AKTX 29.1M
- IPO Year
- MTEX 1999
- AKTX N/A
- Fundamental
- Price
- MTEX $10.00
- AKTX $1.34
- Analyst Decision
- MTEX
- AKTX
- Analyst Count
- MTEX 0
- AKTX 0
- Target Price
- MTEX N/A
- AKTX N/A
- AVG Volume (30 Days)
- MTEX 1.7K
- AKTX 31.7K
- Earning Date
- MTEX 05-20-2025
- AKTX 05-19-2025
- Dividend Yield
- MTEX N/A
- AKTX N/A
- EPS Growth
- MTEX N/A
- AKTX N/A
- EPS
- MTEX 1.32
- AKTX N/A
- Revenue
- MTEX $117,866,000.00
- AKTX N/A
- Revenue This Year
- MTEX N/A
- AKTX N/A
- Revenue Next Year
- MTEX N/A
- AKTX N/A
- P/E Ratio
- MTEX $7.58
- AKTX N/A
- Revenue Growth
- MTEX N/A
- AKTX N/A
- 52 Week Low
- MTEX $6.75
- AKTX $0.85
- 52 Week High
- MTEX $16.49
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- MTEX 49.29
- AKTX 52.40
- Support Level
- MTEX $9.70
- AKTX $1.34
- Resistance Level
- MTEX $11.90
- AKTX $1.46
- Average True Range (ATR)
- MTEX 0.26
- AKTX 0.13
- MACD
- MTEX -0.03
- AKTX -0.01
- Stochastic Oscillator
- MTEX 24.00
- AKTX 56.36
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).